The 340B drug pricing program is a federal program that requires drug manufacturers to provide outpatient drugs to eligible healthcare organizations and covered entities at significantly reduced prices. This program aims to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services.
Episode 135679 discusses how University Health Kansas City is providing 340B discounted prescription drugs directly to uninsured and underinsured patients, highlighting the program's benefits, operational details, and challenges posed by drug company restrictions. The episode also covers the latest news on Johnson & Johnson's controversial 340B rebate model.
Episode 121653 provides guidance for 340B hospitals on navigating the annual recertification process to maintain eligibility for the 340B drug pricing program, covering the importance of recertification, key roles involved, best practices, and resources available from 340B Health to assist hospitals.
Episode 121658 explores how WVU Medicine is using an AI-powered 'bot' to streamline and improve its 340B internal auditing processes, including flagging potential issues and increasing the number of audited claims.